U.S. Percutaneous Coronary Intervention Guidelines (Revised Version 2005)

Author: Yan Hongbing Ma Changsheng Huo Yong
Publisher:
Publish Date: 2006-02-01
Features: This guide interprets the real-world applications of drug-eluting stents. Other highlights of this guide include: ① Revised recommendations on the use of anticoagulant drugs such as clopidogrel, low-molecular-weight heparin, and bivalirudin before, during, and after percutaneous coronary intervention (PCI); ② Added recommendations on the use of distal protection devices; ③ Described the current status of emergency PCI; ④ Added recommendations on early follow-up for left main coronary artery PCI patients; ⑤ Added strategies to ensure optimal treatment outcomes and control medical quality. In summary, the new edition of the percutaneous coronary intervention guide comprehensively reflects the current development status of the field in the United States, serving as a guiding document for clinical practice and our Chinese colleagues to learn from.